- Life Expectancy Could Decline Worldwide Due to COVID-19
- Potential COVID-19 Drug Could Increase Heart Risk: Study
- Holidays Can Be a Fright for Kids With Food Allergies
- Clear Danger: Glass-Topped Tables Injure Thousands Each Year
- COVID Survivor Rita Wilson Wants You to Get Your Flu Shot
- U.S. COVID Death Toll Nears 200,000, While Cases Start to Climb Again
- Health Highlights: Sept. 21, 2020
- How to Help Ensure Your Students Get Enough Sleep
- A Guide to Acne Care for People of Color
- Supreme Court Justice Ruth Bader Ginsburg Dies at 87
Clinical Trials Update: April 2, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Relapsing Remitting Multiple Sclerosis
This study of an investigational drug taken every four weeks is for people who have relapsing remitting multiple sclerosis.
The research site is in Sunrise, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Tinnitus (Ringing of the Ears)
This 29-week study will evaluatie an investigational drug in people with tinnitus. Candidates must be at aged 18 to 75 and have persistent tinnitus in one or both ears.
The research site is in Gilbert, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/tinnitus.aspx.
—–
Gout
Participants in this study of gout will receive study-related medication, doctor visits, possible compensation and transportation.
The research site is in Costa Mesa, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
